1. Istat. Demographic Balance for the year 2020. 2021 5 June 2021; Istituto Italiano di Statistica:[Available from: http://demo.istat.it/bilmens/index.php?anno=2020&lingua=eng.
2. JHU. Mortality analyses. 2021 4 June 2021]; John Hopkins University & Medicine:[Available from: https://coronavirus.jhu.edu/data/mortality.
3. Eurostat. Excess mortality - statistics 2021 10 june 2021; Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Excess_mortality_-_statistics.
4. ISS. Impatto dell'epidemia COVID-19 sulla mortalità totale della popolazione residente, anno 2020. 2021 4 June 2021]; Istituto Nazionale di Statistica:[Available from: https://www.istat.it/it/files/2021/03/Report_ISS_Istat_2020_5_marzo.pdf.
5. Fabiani, M.O., G.; Boros, S.; Spuri, M.; Minelli, G.; Urdiales, A.M.; Andrianou, X.; Riccardo, F.; Del Manso, M.; Petrone, D.; Palmieri, L.; Vescio, M.F.; Bella, A.; Pezzotti, P. Case fatality rate of SARS-CoV-2 infection at regional level and across different phases of the epidemic in Italy. Version of January 20, 2021. Rapporto ISS COVID-19 2021; n. 1/2021:[Available from: https://www.iss.it/rapporti-covid-19/-/asset_publisher/btw1J82wtYzH/content/rapporto-isscovid-19-il-case-fatality-rate-dell-infezione-sars-cov-2-a-livello-regionale-e-attraverso-le-differenti-fasi-dell-epidemia-in-italia.-versione-del-20-gennaio-2021.
6. Gude-Sampedro, F., et al., Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study. Int J Epidemiol, 2021. 50(1): p. 64-74.
7. Palmieri, L., et al., Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci, 2020. 75(9): p. 1796-1800.
8. Mohamed, M.O., et al., Sex Differences in Mortality Rates and Underlying Conditions for COVID-19 Deaths in England and Wales. Mayo Clin Proc, 2020. 95(10): p. 2110-2124.
9. Atkins, J.L., et al., Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort. J Gerontol A Biol Sci Med Sci, 2020. 75(11): p. 2224-2230.
10. de Lusignan, S., et al., Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network. J Infect, 2020. 81(5): p. 785-792.
11. Noor, F.M. and M.M. Islam, Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health, 2020. 45(6): p. 1270-1282.
12. Palmieri, L., et al., Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy. Aging Clin Exp Res, 2021. 33(1): p. 193-199.
13. Kaeuffer, C., et al., Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Euro Surveill, 2020. 25(48).
14. Di Girolamo, C., et al., Socioeconomic inequalities in overall and COVID-19 mortality during the first outbreak peak in Emilia-Romagna Region (Northern Italy). Epidemiol Prev, 2020. 44(5-6 Suppl 2): p. 288-296.
15. Fortuna, D., E. Berti, and M.L. Moro, Multimorbidity epidemiology and health care utilization through combined healthcare administrative databases. Epidemiol Prev, 2021. 45(1-2): p. 62-71.
16. Spadea, T.D.G., C.; Landriscina, T.; Leoni, O.; Forni, S.; Colais, P.; Fanizza, C.; Allotta, A.; Onorati, R.; Gnavi R. Monitoring the indirect impact of Covid-19 on hospital care pathways in Italy: results from the Mimico-19 network. 2021; Available from: https://www.researchsquare.com/article/rs-653542/v1.
17. Istat-Iss. Impatto dell’epidemia COVID-19 sulla mortalità totale della popolazione residente. Anno 2020 e gennaio-aprile 2021. Istituto Nazione di Statistica:[Available from: https://www.istat.it/it/files//2021/06/Report_ISS_Istat_2021_10_giugno.pdf.
18. Richards, N.R.J. Can dying at home during COVID-19 still be indicator of 'quality of death'? 2021 2021]; Available from: https://policyscotland.gla.ac.uk/can-dying-at-home-during-covid-19-still-be-an-indicator-of-quality-of-death/.
19. Raleigh, V. Invisible deaths: understanding why deaths at home increased during the Covid-19 pandemic. 2021 2021]; Available from: https://www.kingsfund.org.uk/blog/2021/06/understanding-why-deaths-home-increased-covid-19-pandemic.
20. Graham, N.S.N., et al., SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J Infect, 2020. 81(3): p. 411-419.
21. Ballotari, P., et al., [Excess mortality risk in nursing care homes before and during the COVID-19 outbreak in Mantua and Cremona provinces (Lombardy Region, Northern Italy)]. Epidemiol Prev, 2020. 44(5-6 Suppl 2): p. 282-287.
22. Istat. Luogo del decesso, marzo-aprile 2020. 2021]; Available from: https://www.istat.it/it/files//2021/04/CauseMortePrima_PandemiaCard4.pdf.
23. Burki, T., England and Wales see 20 000 excess deaths in care homes. Lancet, 2020. 395(10237): p. 1602.
24. Nemani, K., et al., Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. JAMA Psychiatry, 2021. 78(4): p. 380-386.
25. Kuroda, N., Epilepsy and COVID-19: Updated evidence and narrative review. Epilepsy Behav, 2021. 116: p. 107785.
26. Mangone, L., et al., Cumulative COVID-19 incidence, mortality and prognosis in cancer survivors: A population-based study in Reggio Emilia, Northern Italy. Int J Cancer, 2021. 149(4): p. 820-6.
27. Shi, C., et al., Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis, 2021. 21(1): p. 663.
28. Trifirò, G., et al., Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients. Drug Saf, 2020. 43(12): p. 1297-1308.